Phenotypic diversity and mechanisms of drug-resistance in leukaemic cells

Hodgkin's Disease in 50 Intravenous Drug Users with HIV-Infection.

Leukemia & lymphoma·2016

Induction and Persistence of Complete Remission in a Resistant Acute Myeloid Leukemia Patient after Treatment with Recombinant Interleukin-2.

Leukemia & lymphoma·2016

Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs.

Cancer·1993

Has IL2 a role in the management of minimal residual disease for acute leukemia?

Leukemia·1992

Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study.

Leukemia·1992

Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings.

Leukemia·1992

Mitochondrial dysfunction in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using venetoclax.

Haematologica·2026

In vivo efficacy of the novel anti-microtubule inhibitor E7130 in preclinical models of early T-cell precursor acute lymphoblastic leukemia.

Haematologica·2026

Menin inhibition with revumenib clears measurable residual disease in acute myeloid leukemia with UBTF tandem duplication after allogeneic stem cell transplantation.

Haematologica·2026

Risk of immune thrombocytopenia following COVID-19 vaccination and SARS-CoV-2 infection.

Haematologica·2026

Degrading the BTK and blocking BCL2: a new path in marginal zone lymphomas.

Haematologica·2026

Human cell models for inherited platelet disorders: strengths, limitations and emerging technologies.

Haematologica·2026

Comparative Cardiovascular Outcomes in Acalabrutinib vs. Zanubrutinib in B-Cell Malignancies: A TriNetX Data Study.

Current oncology (Toronto, Ont.)·2026

Challenges of Conducting a Feasibility Pilot Randomized Controlled Trial During COVID-19 Restrictions: Rivaroxaban Versus Acetyl Salicylic Acid in Patients with Multiple Myeloma on Lenalidomide-Based Therapy (RithMM).

Current oncology (Toronto, Ont.)·2026

Secondary Intracranial Hypertension During ATRA/ATO Therapy in High-Risk Acute Promyelocytic Leukemia: A Case Report and Practical Management Framework.

Current oncology (Toronto, Ont.)·2026

Patient-Reported Burden and Clinical Spectrum of Rheumatic Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy in Lung Cancer: A Real-World Cohort Study.

Current oncology (Toronto, Ont.)·2026

Male Sex, Early Postoperative C-Reactive Protein and Prolonged Hospital Stay After Lung Resection in Older Patients: A Retrospective Cohort Study.

Diseases (Basel, Switzerland)·2026

Catalase Activity and Methylglyoxal Concentration in Plasma and Erythrocytes Across Different Clinical Phenotypes of Thyroid Disease: A Cross-Sectional Study.

Diseases (Basel, Switzerland)·2026

Related Experiment Videos

Phenotypic diversity and mechanisms of drug-resistance in leukaemic cells

Related Concept Videos

Hodgkin's Disease in 50 Intravenous Drug Users with HIV-Infection.

Induction and Persistence of Complete Remission in a Resistant Acute Myeloid Leukemia Patient after Treatment with Recombinant Interleukin-2.

Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs.

Has IL2 a role in the management of minimal residual disease for acute leukemia?

Autologous bone marrow transplantation followed by interleukin-2 in children with advanced leukemia: a pilot study.

Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings.

Mitochondrial dysfunction in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using venetoclax.

In vivo efficacy of the novel anti-microtubule inhibitor E7130 in preclinical models of early T-cell precursor acute lymphoblastic leukemia.

Menin inhibition with revumenib clears measurable residual disease in acute myeloid leukemia with UBTF tandem duplication after allogeneic stem cell transplantation.

Risk of immune thrombocytopenia following COVID-19 vaccination and SARS-CoV-2 infection.

Degrading the BTK and blocking BCL2: a new path in marginal zone lymphomas.

Human cell models for inherited platelet disorders: strengths, limitations and emerging technologies.

Comparative Cardiovascular Outcomes in Acalabrutinib vs. Zanubrutinib in B-Cell Malignancies: A TriNetX Data Study.

Challenges of Conducting a Feasibility Pilot Randomized Controlled Trial During COVID-19 Restrictions: Rivaroxaban Versus Acetyl Salicylic Acid in Patients with Multiple Myeloma on Lenalidomide-Based Therapy (RithMM).

Secondary Intracranial Hypertension During ATRA/ATO Therapy in High-Risk Acute Promyelocytic Leukemia: A Case Report and Practical Management Framework.

Patient-Reported Burden and Clinical Spectrum of Rheumatic Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy in Lung Cancer: A Real-World Cohort Study.

Male Sex, Early Postoperative C-Reactive Protein and Prolonged Hospital Stay After Lung Resection in Older Patients: A Retrospective Cohort Study.

Catalase Activity and Methylglyoxal Concentration in Plasma and Erythrocytes Across Different Clinical Phenotypes of Thyroid Disease: A Cross-Sectional Study.

Related Experiment Videos

Phenotypic diversity and mechanisms of drug-resistance in leukaemic cells

Related Concept Videos

Related Articles